These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 315864)

  • 1. Effect of dopamine-beta-hydroxylase inhibitor (disulfiram) on the response of adenohypophysis, serum ceruloplasmin and hypothalamic ascorbic acid to estradiol treatment.
    Schreiber V; Pribyl T; Jahodová J
    Endocrinol Exp; 1979 Sep; 13(3):131-8. PubMed ID: 315864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation oestradiol effects by silver nitrate: inhibition of the adenohypophyseal reaction, block of the ceruloplasmin increase and block of hypothalamic ascorbic acid depletion.
    Schreiber V; Pribyl T; Jahodová J
    Endokrinologie; 1980 Oct; 76(2):129-36. PubMed ID: 7449747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactions of hypothalamic ascorbic acid, serum ceruloplasmin and the adenohypophysis to oestradiol: inhibition by L-thyroxine.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1980; 29(1):11-20. PubMed ID: 6444734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic modulation of the adenohypophyseal reaction to oestradiol: interaction of perphenazine with the thyroid hormones.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1980; 29(2):173-9. PubMed ID: 6446099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations between adenohypophyseal weight, serum polyphenol oxidase activity (ceruloplasmin) and hypothalamic ascorbic acid after estrogen treatment in rats.
    Schreiber V; Pribyl T; Jahodová J
    Horm Metab Res; 1980 Mar; 12(3):97-9. PubMed ID: 7372274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by an ergoline derivative (dopaminergic agonist) of oestradiol-induced adenohypophyseal growth and of the decrease in the hypothalamic ascorbic acid (HAA) concentration in rats.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1982; 31(2):97-100. PubMed ID: 6212960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of perphenazine and an ergoline derivative on oestrogen-induced adenohypophyseal growth.
    Schreiber V; Pribyl T
    Physiol Bohemoslov; 1977; 26(1):31-8. PubMed ID: 140398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the oestradiol-induced increase in adenohypophyseal weight and in hypothalamic and serum polyphenol oxidase activity by dopaminergic agonists.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1983; 32(2):117-20. PubMed ID: 6408657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic control of adenohypophyseal growth.
    Schreiber V
    Vopr Biokhim Mozga; 1978; 13():221-7. PubMed ID: 756643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of disulfiram and sodium diethyldithiocarbamate on tyrosine and dopamine-beta-hydroxylases activities in rat brain and heart.
    Szmigielski A
    Pol J Pharmacol Pharm; 1975; 27(2):153-9. PubMed ID: 239395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioestrogenic action of the aldosterone antagonist canrenoate K in the rat (adenohypophysis, ceruloplasmin).
    Schreiber V; Pribyl T
    Physiol Bohemoslov; 1977; 26(5):385-95. PubMed ID: 144921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restitution of endocrine changes after discontinuing chronic oestradiol administration in rats.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1978; 27(6):505-13. PubMed ID: 152926
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopamine-beta-hydroxylase inhibitors modulate the concentration of functional estrogen receptors in female rat hypothalamus and pituitary gland.
    Blaustein JD; Brown TJ; Swearengen ES
    Neuroendocrinology; 1986; 43(2):150-8. PubMed ID: 3014364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic control of adenohypophysial weight and serum ceruloplasmin level in rats.
    Schreiber V; Pribyl T
    Neuroendocrinology; 1976; 21(1):58-67. PubMed ID: 1004686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrelation between anterior pituitary weight and ceruloplasmin level in serum after estrogen administration in male rats.
    Schreiber V; Pribyl T
    Endocrinol Exp; 1976 Jun; 10(2):125-9. PubMed ID: 1084267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between the weight of adenohypophysis, thyroxine-binding adenohypophyseal proteins in vitro and level of ceruloplasmin in the rat serum: effect of hormones and of various neurotrophic drugs].
    Schreiber V
    Cesk Fysiol; 1976; 25(1):31-4. PubMed ID: 815007
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of 8-prenylnaringenin on the hypothalamo-pituitary-uterine axis in rats after 3-month treatment.
    Christoffel J; Rimoldi G; Wuttke W
    J Endocrinol; 2006 Mar; 188(3):397-405. PubMed ID: 16522720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of gonadal steroids on hypothalamic and pituitary RNA and protein synthesis in rats.
    Bíró J
    Endocrinol Exp; 1979; 13(4):209-16. PubMed ID: 316384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of anterior pituitary dopamine receptors by estradiol 17-beta: dose-response relationship.
    Ali SF; Peck EJ
    J Neurosci Res; 1985; 13(4):497-507. PubMed ID: 4009741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of interaction of oestrogen, testosterone and thyroid hormones on the serum ceruloplasmin level in rats.
    Schreiber V; Pribyl T
    Physiol Bohemoslov; 1977; (2):129-37. PubMed ID: 140385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.